Related Experiment Video
Updated: Mar 7, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
Infections in severe alcoholic hepatitis.
Eleni Karakike1, Christophe Moreno2, Thierry Gustot3
1Department of Infectious Diseases, CHU Brugmann (Eleni Karakike).
Severe alcoholic hepatitis (sAH) patients face high mortality, with infections being a primary cause of death. Early detection and treatment of infections are crucial for improving survival in sAH.
Area of Science:
- Hepatology
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe alcoholic hepatitis (sAH) is a critical liver condition with a ~30% one-month mortality rate.
- Corticosteroids are the primary treatment for improving short-term survival in sAH.
- Infections complicate sAH in ~50% of patients, often leading to death despite corticosteroid therapy.
Purpose of the Study:
- To characterize infections in patients with severe alcoholic hepatitis.
- To identify risk factors and common pathogens associated with infections in sAH.
- To highlight the importance of infection screening and management in sAH.
Main Methods:
- Review of existing literature on infections in severe alcoholic hepatitis.
- Analysis of infection characteristics, including causative agents and affected sites.
- Identification of risk factors such as liver failure, recent alcohol consumption, and immunosuppression.
Main Results:
- Infections in sAH are predominantly bacterial, with respiratory tract infections being most common.
- Common pathogens include gram-negative bacilli, alongside opportunistic fungi (e.g., Aspergillus, Pneumocystis) and viruses (e.g., CMV, HSV), often linked to corticosteroid use.
- Risk factors for infection include liver failure, recent alcohol intake, and immunosuppressive medications.
Conclusions:
- Infections are a major cause of mortality in severe alcoholic hepatitis.
- Prompt and thorough infection screening, alongside adequate treatment, is essential for improving patient outcomes.
- Further research and well-designed trials are needed to evaluate prophylactic strategies for infection prevention in this high-risk group.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

